Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,154.00, giving the company a market capitalization of 1.08T. It carries a P/E multiple of 39.18 and pays a dividend yield of 0.58%.
On 2026-09-19, Eli Lilly(LLY) stock traded between a low of $1,140.30 and a high of $1,157.60. Shares are currently priced at $1,154.00, which is +1.2% above the low and -0.3% below the high.
The Eli Lilly(LLY)'s current trading volume is 4.55M, compared to an average daily volume of 2.24M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Some emerging scientific research points to an increased risk for GLP-1 patients to develop nonarteritic anterior ischemic optic neuropathy, or vision loss, Ale...
...
Analysts are intrested in these 5 stocks: ( (ECHO) ), ( (ENB) ), ( (RIVN) ), ( (IOT) ) and ( (LLY) ). Here is a breakdown of their recent ratings and the ration...
Analyst ratings
84%
of 32 ratingsMore LLY News
...
Investing Can Eli Lilly’s Two-Drug Obesity Treatment Justify Its $1 Trillion Valuation? Eli Lilly stakes its trillion-dollar valuation on mid-stage data for a t...
Eli Lilly (LLY) on Friday announced that the U.S. FDA granted full approval for an all-oral regimen containing its estrogen receptor antagonist Inluriyo and kin...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company is launching a Phase 2 study called FORAY to test vepugr...
Investors piled into growth stocks in recent years, particularly in the area of artificial intelligence (AI), and this movement offered the overall market enorm...
Guggenheim analyst Seamus Fernandez raised the firm’s price target on Eli Lilly (LLY) to $1,284 from $1,273 and keeps a Buy rating on the shares. The firm is up...
Eli Lilly (LLY) just put fresh clinical data at the center of its story, highlighting new results for obesity and diabetes drugs and a genetic medicine collabor...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.